ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,693,000 | +8.1% | 400,201 | +4.2% | 0.01% | 0.0% |
| Q4 2021 | $8,967,000 | +139.6% | 384,207 | +70.5% | 0.01% | +150.0% |
| Q3 2021 | $3,743,000 | -51.8% | 225,320 | -29.2% | 0.00% | -50.0% |
| Q2 2021 | $7,763,000 | +38.7% | 318,306 | +46.8% | 0.00% | +33.3% |
| Q1 2021 | $5,596,000 | -65.2% | 216,890 | -27.8% | 0.00% | -70.0% |
| Q4 2020 | $16,069,000 | +156.0% | 300,576 | +97.5% | 0.01% | +100.0% |
| Q3 2020 | $6,278,000 | -37.2% | 152,193 | -26.2% | 0.01% | -37.5% |
| Q2 2020 | $9,990,000 | +35.3% | 206,115 | +17.9% | 0.01% | +14.3% |
| Q1 2020 | $7,384,000 | +17.1% | 174,770 | +18.5% | 0.01% | +40.0% |
| Q4 2019 | $6,307,000 | +29.0% | 147,428 | +8.5% | 0.01% | +25.0% |
| Q3 2019 | $4,891,000 | +173.4% | 135,892 | +103.0% | 0.00% | +300.0% |
| Q2 2019 | $1,789,000 | +11.7% | 66,927 | +12.2% | 0.00% | 0.0% |
| Q1 2019 | $1,601,000 | +69.1% | 59,638 | +1.8% | 0.00% | 0.0% |
| Q4 2018 | $947,000 | -26.4% | 58,559 | -5.6% | 0.00% | 0.0% |
| Q3 2018 | $1,287,000 | +40.2% | 62,001 | +3.1% | 0.00% | 0.0% |
| Q2 2018 | $918,000 | -0.9% | 60,138 | +46.0% | 0.00% | 0.0% |
| Q1 2018 | $926,000 | -27.0% | 41,203 | -2.2% | 0.00% | 0.0% |
| Q4 2017 | $1,269,000 | -29.8% | 42,147 | -12.2% | 0.00% | -50.0% |
| Q3 2017 | $1,807,000 | +55.0% | 47,977 | +14.8% | 0.00% | +100.0% |
| Q2 2017 | $1,166,000 | -48.2% | 41,797 | -36.1% | 0.00% | -66.7% |
| Q1 2017 | $2,250,000 | +68.8% | 65,443 | +41.5% | 0.00% | +50.0% |
| Q4 2016 | $1,333,000 | -23.4% | 46,235 | -15.5% | 0.00% | -33.3% |
| Q3 2016 | $1,740,000 | +4.4% | 54,705 | +6.5% | 0.00% | 0.0% |
| Q2 2016 | $1,667,000 | +91.0% | 51,346 | +64.5% | 0.00% | +200.0% |
| Q1 2016 | $873,000 | -40.1% | 31,222 | -23.6% | 0.00% | -50.0% |
| Q4 2015 | $1,457,000 | +23.2% | 40,864 | +14.2% | 0.00% | 0.0% |
| Q3 2015 | $1,183,000 | -12.0% | 35,776 | +11.4% | 0.00% | -33.3% |
| Q2 2015 | $1,345,000 | +53.2% | 32,126 | +19.2% | 0.00% | +50.0% |
| Q1 2015 | $878,000 | +24.0% | 26,952 | +20.9% | 0.00% | +100.0% |
| Q4 2014 | $708,000 | +62.0% | 22,301 | +26.3% | 0.00% | 0.0% |
| Q3 2014 | $437,000 | +12.1% | 17,664 | +2.3% | 0.00% | 0.0% |
| Q2 2014 | $390,000 | -24.6% | 17,274 | -18.8% | 0.00% | 0.0% |
| Q1 2014 | $517,000 | -21.5% | 21,268 | -19.4% | 0.00% | -50.0% |
| Q4 2013 | $659,000 | -28.2% | 26,389 | -21.0% | 0.00% | 0.0% |
| Q3 2013 | $918,000 | +39.9% | 33,417 | -7.5% | 0.00% | 0.0% |
| Q2 2013 | $656,000 | – | 36,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |